Literature DB >> 17950082

Gelsolin is depleted in post-shock mesenteric lymph.

Janeen R Jordan1, Ernest E Moore, Sagar S Damle, Phillip Eckels, Jeffrey L Johnson, Jonathan P Roach, Jasmina S Redzic, Kirk C Hansen, Anirban Banerjee.   

Abstract

BACKGROUND: Gelsolin is a plasma protein that functions to depolymerize actin filaments preventing capillary plug formation following tissue injury. It also functions to mediate the inflammatory response by binding proinflammatory lipids such as lysophosphatidic acid, sphingosine-1-phosphate and phosphoinositides. Clinically, reduced gelsolin concentrations have been associated with increased mortality in critically ill, trauma, and burn patients. We have previously shown that following hemorrhagic shock with splanchnic hypoperfusion, mesenteric lymph contains lipid components that cause neutrophil and EC activation and that protein concentrations are severely diluted due to resuscitation. We hypothesized that lipid binding proteins such as gelsolin may be depleted after trauma/hemorrhagic shock leading to increased lipid bioactivity.
METHODS: Shock was induced in SD rats by controlled hemorrhage and the mesenteric duct cannulated for lymph collection. Resuscitation was performed by infusing 2x SB volume in NS over 30 min, followed by 1/2 SB volume over 30 min, then 2x SB volume in NS over 60 min. Pre and post-shock lymph was loaded at equal protein concentrations on 2D-gels, followed by trypsin digestion and identification with mass spectrometry (MS-MS). Proteomics data were confirmed with Western blotting then quantitated by densitometry. Analysis of variance was used evaluate statistical data.
RESULTS: Gelsolin decreased in mesenteric lymph following hemorrhagic shock.
CONCLUSIONS: Gelsolin is found at high levels (comparable to plasma) in mesenteric lymph. Following hemorrhagic shock, gelsolin levels decrease significantly, possibly due to consumption by the actin scavenging system. The magnitude of this change in concentration could release lipid bioactivity and predispose the lung and other organs to capillary injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950082      PMCID: PMC2695490          DOI: 10.1016/j.jss.2007.04.017

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  30 in total

1.  Factors in intestinal lymph after shock increase neutrophil adhesion molecule expression and pulmonary leukosequestration.

Authors:  Joseph M Caruso; Eleonora Feketeova; Sara D Dayal; Carl J Hauser; Edwin A Deitch
Journal:  J Trauma       Date:  2003-10

2.  Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation.

Authors:  S E Lind; D B Smith; P A Janmey; T P Stossel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

3.  Bioactivity of postshock mesenteric lymph depends on the depth and duration of hemorrhagic shock.

Authors:  Tomohiko Masuno; Ernest E Moore; Aaron M Cheng; Eric L Sarin; Anirban Banerjee
Journal:  Shock       Date:  2006-09       Impact factor: 3.454

4.  Shock mesenteric lymph-induced rat polymorphonuclear neutrophil activation and endothelial cell injury is mediated by aqueous factors.

Authors:  Saraswati D Dayal; Carl J Hauser; Eleanora Feketeova; Zoltan Fekete; John M Adams; Qi Lu; Da-Zhong Xu; Sergei Zaets; Edwin A Deitch
Journal:  J Trauma       Date:  2002-06

5.  Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction.

Authors:  Patricia A Rothenbach; Benny Dahl; Jason J Schwartz; Grant E O'Keefe; Masaya Yamamoto; William M Lee; Jureta W Horton; Helen L Yin; Richard H Turnage
Journal:  J Appl Physiol (1985)       Date:  2003-05-02

6.  Post-hemorrhagic shock mesenteric lymph activates human pulmonary microvascular endothelium for in vitro neutrophil-mediated injury: the role of intercellular adhesion molecule-1.

Authors:  Ricardo J Gonzalez; Ernest E Moore; David J Ciesla; Joao R Nieto; Jeffrey L Johnson; Christopher C Silliman
Journal:  J Trauma       Date:  2003-02

7.  Lysophosphatidic acid increases phosphatidic acid formation, phospholipase D activity and degranulation by human neutrophils.

Authors:  Jen-Sie Tou; Jacquelyn S Gill
Journal:  Cell Signal       Date:  2005-01       Impact factor: 4.315

8.  Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients.

Authors:  Po-Shun Lee; Leslie R Drager; Thomas P Stossel; Francis D Moore; Selwyn O Rogers
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

9.  A study of the biologic activity of trauma-hemorrhagic shock mesenteric lymph over time and the relative role of cytokines.

Authors:  Marson T Davidson; Edwin A Deitch; Qi Lu; Adena Osband; Eleonora Feketeova; Zoltán H Németh; Gyorgy Haskó; Da-Zhong Xu
Journal:  Surgery       Date:  2004-07       Impact factor: 3.982

10.  Trauma-hemorrhagic shock mesenteric lymph induces endothelial apoptosis that involves both caspase-dependent and caspase-independent mechanisms.

Authors:  Marson T Davidson; Edwin A Deitch; Qi Lu; György Haskó; Billy Abungu; Zoltán H Németh; Sergey B Zaets; Lawrence D Gaspers; Andrew P Thomas; Da-Zhong Xu
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

View more
  10 in total

1.  Carrying yourself: self antigen composition of the lymphatic fluid.

Authors:  Laura Santambrogio; Lawrence J Stern
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

Review 2.  Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.

Authors:  Gabor J Tigyi; Leonard R Johnson; Sue Chin Lee; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Karin Thompson; Alyssa Boler; W Shannon McCool
Journal:  J Lipid Res       Date:  2019-01-28       Impact factor: 5.922

Review 3.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

4.  Proteome and system ontology of hemorrhagic shock: exploring early constitutive changes in postshock mesenteric lymph.

Authors:  Erik D Peltz; Ernest E Moore; Ashley A Zurawel; Janeen R Jordan; Sagar S Damle; Jasmina S Redzic; Tomohiko Masuno; John Eun; Kirk C Hansen; Anirban Banerjee
Journal:  Surgery       Date:  2009-06-25       Impact factor: 3.982

5.  Dynamic changes in rat mesenteric lymph proteins following trauma using label-free mass spectrometry.

Authors:  Angelo D'Alessandro; Monika Dzieciatkowska; Erik D Peltz; Ernest E Moore; Janeen R Jordan; Christopher C Silliman; Anirban Banerjee; Kirk C Hansen
Journal:  Shock       Date:  2014-12       Impact factor: 3.454

Review 6.  Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome.

Authors:  Laura Santambrogio; Hans-Georg Rammensee
Journal:  Immunogenetics       Date:  2018-10-20       Impact factor: 2.846

7.  Proteomic profiling of the mesenteric lymph after hemorrhagic shock: Differential gel electrophoresis and mass spectrometry analysis.

Authors:  Ashley Zurawel; Ernest E Moore; Erik D Peltz; Janeen R Jordan; Sagar Damle; Monika Dzieciatkowska; Anirban Banerjee; Kirk C Hansen
Journal:  Clin Proteomics       Date:  2010-11-10       Impact factor: 3.988

8.  Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury.

Authors:  Qing-Hong Zhang; Qi Chen; Jia-Rui Kang; Chen Liu; Ning Dong; Xiao-Mei Zhu; Zhi-Yong Sheng; Yong-Ming Yao
Journal:  J Neuroinflammation       Date:  2011-09-21       Impact factor: 8.322

9.  Tranexamic acid decreases rodent hemorrhagic shock-induced inflammation with mixed end-organ effects.

Authors:  Patrick F Walker; Anthony D Foster; Philip A Rothberg; Thomas A Davis; Matthew J Bradley
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

Review 10.  Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target.

Authors:  Ewelina Piktel; Ilya Levental; Bonita Durnaś; Paul A Janmey; Robert Bucki
Journal:  Int J Mol Sci       Date:  2018-08-25       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.